Clinical Trial Update: Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating eFT226 in adults with selected advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• eFT226 (eFT226)

Snippet

Sponsor: Effector Therapeutics | Conditions: Solid Tumor, Adult | Phase 1, Phase 2 | Status: RECRUITING